Details for New Drug Application (NDA): 075401
✉ Email this page to a colleague
NDA 075401 describes TAZTIA XT, which is a drug marketed by Actavis Labs Fl Inc and is included in one NDA. Additional details are available on the TAZTIA XT profile page.
The generic ingredient in TAZTIA XT is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
The generic ingredient in TAZTIA XT is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Summary for 075401
| Tradename: | TAZTIA XT |
| Applicant: | Actavis Labs Fl Inc |
| Ingredient: | diltiazem hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 120MG | ||||
| Approval Date: | Apr 10, 2003 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 180MG | ||||
| Approval Date: | Apr 10, 2003 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 240MG | ||||
| Approval Date: | Apr 10, 2003 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
